Zobrazeno 1 - 10 of 31 pro vyhledávání: '"Ömer, Karadağ"'
1
Akademický článek
Factors Associated with the Development of Anti-drug Antibodies to TNFi and the Consequences for Axial Spondyloarthritis: A Two-year Follow-up Study
Autor: Elif Durak Ediboğlu, Muhammed Çınar, Didem Kozacı, Dilek Solmaz, Gökhan Sargın, Ömer Karadağ, Gülay Kınıklı, Umut Kalyoncu, Sedat Yılmaz, Taşkın Şentürk, Gökhan Kabadayı, Gökhan Keser, Gülen Hatemi, Kübra Kaya, Mustafa Özmen, Figen Yargucu, Yeşim Özgüler, Ayşe Cefle, Önay Gerçik, Bünyamin Kısacık, Servet Akar
Publikováno v: European Journal of Rheumatology, Vol 11, Iss 3, Pp 364-370 (2024)
Objective: To evaluate the development of anti-drug antibodies (ADAb) against tumor necrosis factor inhibitors (TNFi) therapy during a 2-year period and search the factors linked to patients with axial spondyloarthritis (axSpA). Methods: Biologic-
Externí odkaz: https://doaj.org/article/206e6f37a9da4964bb146e29fcf5b6a2
Zobrazit plný text záznamu
3
Akademický článek
Cerebral Vasomotor Reactivity in Medically Stabilized Patients with Takayasu’s Arteritis
Autor: Mehmet Yasir Pektezel, Sahip Rovshanov, Ertuğrul Cağrı Bölek, Farid Khasiyev, Ömer Karadağ, Ethem Murat Arsava, Mehmet Akif Topçuoğlu
Publikováno v: Türk Nöroloji Dergisi, Vol 27, Iss 2, Pp 123-127 (2021)
Objective: Takayasu arteritis (TA) is a large vessel vasculitis that affects the aorta and its main branches in the young population. Although data about the effects of controlling disease activity with immunosuppressive treatments on cerebral circul
Externí odkaz: https://doaj.org/article/5086cfdc0d55425186d28824384b6b60
Zobrazit plný text záznamu
8
Akademický článek
Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factor
Autor: Şule Apraş Bilgen, Umut Kalyoncu, Abdülsamed Erden, Uğur Canpolat, Levent Kılıç, Ömer Karadağ, Kudret Aytemir, Sedat Kiraz, Ali Akdoğan, İhsan Ertenli
Publikováno v: Türk Kardiyoloji Derneği Arşivi, Vol 46, Iss 5, Pp 358-365 (2018)
Objective: Cardiovascular disease (CVD) is more prevalent in almost all patients with chronic inflammatory musculoskeletal diseases than in their healthy counterparts. The aim of this study was to assess the presence of subclinical atherosclerosis in
Externí odkaz: https://doaj.org/article/8dbdc7f5af994329a5f372bd5e5eb937
Zobrazit plný text záznamu
9
Is the impact of biologic agents in enteropathic spondylitis different from other spondylitis? Real life data from the HUR-BIO Registry
Autor: Bayram, Farisoğulları, Gözde Kübra, Yardımcı, Alper, Sarı, Emre, Bilgin, Ertuğrul Çağrı, Bölek, Emine, Duran, Levent, Kılıç, Ali, Akdoğan, Ömer, Karadağ, Şule, Apraş Bilgen, Ali İhsan, Ertenli, Sedat, Kiraz, Umut, Kalyoncu
Publikováno v: Clinical and Experimental Rheumatology. 40:112-119
To compare enteropathic spondylitis (ES) with psoriatic spondylitis (PS) and ankylosing spondylitis (AS), in patients on biological disease-modifying anti-rheumatic drug (bDMARD) treatment.Patients who were enrolled in the HUR-BIO registry were inclu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8b95c3a8bd225c0b8473ce2963e84c5
https://doi.org/10.55563/clinexprheumatol/uxcofr
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje